Microbix Invests to Further Scale Its Businesshttps://microbix.com/microbix-invests-to-further-scale-its-business/ March 29, 2022 – Microbix Biosystems Inc. (TSX: MBX) announces investment in programs to upgrade, digitize and fully-integrate its Quality Management System (“QMS”) and its Enterprise Resource Planning (“ERP”) platforms – to better enable its business growth trajectory. These initiatives will support more rapid growth in each of Microbix’s business lines – its test ingredients business (antigens), its test Quality Assessment Products (“QAPs™”), and its Viral Transport Medium (“DxTM™”).